English
Strategic development and validation of a stability-indicating analytical method for S-adenosylmethionine
Mayur S. Bhamare
Ganesh B. Sonawane
Vijayraj N. Sonawane
Chandrashekar D. Patil
Rushikesh L. Bachhav
Sunil K. Mahajan
Dipak D. Sonawane
Abstract
S-Adenosylmethionine (SAMe) is a biologically essential compound involved in DNA methylation, liver detoxification, neurotransmitter synthesis, and joint health. Due to its instability and susceptibility to degradation, a validated analytical method is crucial for its accurate quantification and quality control. This research focuses on the development, validation, and stability assessment of a refined RP-HPLC method for the quantification of S-adenosylmethionine (SAMe) in both bulk material and pharmaceutical formulations. The method development involved selecting an appropriate mobile phase and wavelength, optimizing chromatographic conditions, and validating the method according to the standards outlined in International Conference on Harmonisation (ICH Q2R1). Forced degradation experiments were carried out under thermal, photolytic, acid, base, and oxidative stress conditions to assess stability. The optimized RP-HPLC method, with a mobile phase of ACN/0.1% OPA aqueous solution (20:80, v/v) and a detection wavelength of 259 nm, demonstrated high precision, linearity (R² = 0.99996), and accuracy (recovery between 98-102%). The method effectively detected degradation products, establishing the method’s capability to indicate stability. The optimized RP-HPLC method demonstrated simplicity, accuracy, precision, and robustness for the quantitative analysis and stability evaluation of S-adenosylmethionine (SAMe). It is well-suited for quality control applications and aligns with regulatory standards, offering a reliable tool for routine analysis of SAMe in pharmaceutical formulations.
Keywords:
S-adenosylmethionine, method development, forced degradation, pharmaceutical analysis, RP-HPLCSimilar Articles
- Barbara Krassowska-Świebocka, Piotr Rudzki, FORMATION OF DIARYLIODONIUM SALTS AND IODYLOARENES AND THEIR USE IN MODERN ORGANIC SYNTHESIS , Prospects in Pharmaceutical Sciences: Vol. 2 No. 1 (2004)
- Joanna Warguła, Outline of the history of drug synthesis with particular emphasis on anticancer and antibacterial drugs , Prospects in Pharmaceutical Sciences: Vol. 20 No. 3 (2022)
- Ewa Napiórkowska, Thiamine: overview of history of discovery, mechanism of action, role and deficiency , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
- Sylwester Krukowski, SYNTHESIS AND STRUCTURAL STUDIES OF CALCIUM HYDROXYAPATITES MODIFIED WITH AMINO ACIDS , Prospects in Pharmaceutical Sciences: Vol. 11 No. 7 (2013)
- Małgorzata Krzyżanowska, Katarzyna Kozon, Jakub Olszewski, Andrzej Patyra, Efficacy of satralizumab therapy in the treatment of NMOSD , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
- Małgorzata Idzikowska, Marta Janczura, Tomasz Lepionka, Michał Madej, Edyta Mościcka, Justyna Pyzik, Paulina Siwek, Weronika Szubierajska, Dorota Skrajnowska, Andrzej Tokarz, NANOTECHNOLOGY IN FOOD PRODUCTION – DEVELOPMENT, RISKS AND REGULATORY ASPECTS , Prospects in Pharmaceutical Sciences: Vol. 10 No. 4 (2012)
- Nuh Kormaz, Falah Saleh Mohammed, Imran Uysal, Mustafa Sevindik, Antioxidant, antimicrobial and anticholinesterase activity of Dittrichia graveolens , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
- Olga Ciepiela, Patrycja Dąbrowska, Helena Donica, A. Goliszek, Ireneusz P. Grudziński, J. Jedlińska, Maciej Korpysz, Paweł Kozłowski, Natalia Krześniak, Kamila Marciniec, D. Mika, K. Ołownia, Aleksandra Ozygała, Monika Paskudzka, J. Rachuna, Klaudia Radoszkiewicz, K. Rozmianiec, Mariusz Rozwandowicz, Anna Sarnowska, D. Sitarz, K. Szafraniec, Magdalena Szymańska, Monika Szymoniak, Marcin Śmiarowski, WARSZAWSKA JESIEŃ DIAGNOSTYCZNA , Prospects in Pharmaceutical Sciences: Vol. 21 No. S1 (2023): Konferencja naukowo-szkoleniowa Warszawska Jesień Diagnostyczna 28.09.-29.09.2023
- Grzegorz Nałęcz-Jawecki, WATER ENVIROMENT TOXICITY INVESTIGATED BY BIOASSAYS , Prospects in Pharmaceutical Sciences: Vol. 1 No. 2 (2003)
- Andrzej Tokarz, Małgorzata Jelińska, Agnieszka Ozga, ISOPROSTANES - NEW BIOMARKERS IN LIPID PEROXIDATION IN VIVO , Prospects in Pharmaceutical Sciences: Vol. 2 No. 2 (2004)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
You may also start an advanced similarity search for this article.
Details
References
Statistics
Authors
Citation rules
Cited by / Share
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.